Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
2(11%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
10
53%
Ph phase_4
1
5%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.6%

11 of 13 finished

Non-Completion Rate

15.4%

2 ended early

Currently Active

2

trials recruiting

Total Trials

19

all time

Status Distribution
Active(2)
Completed(11)
Terminated(2)
Other(4)

Detailed Status

Completed11
unknown4
Withdrawn2
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (9.1%)
N/A10 (90.9%)

Trials by Status

completed1158%
unknown421%
active_not_recruiting15%
recruiting15%
withdrawn211%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT06657209Phase 4

Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide

Recruiting
NCT05567692

Subjects With T2D or at Risk of T2D Cohort Follow-up

Active Not Recruiting
NCT06141291Not Applicable

Bed Rest Study SBI 2023

Completed
NCT05377502

Performance and Patient Acceptance of a Commercially Available Beverage as Compared to an Oral Glucose Solution for Oral Glucose Tolerance Tests in Cystic Fibrosis (CF) Patients Who Are Screened for CF-related Diabetes.

Unknown
NCT02653027Not Applicable

Effect of Lumacaftor-ivacaftor on Glucose Handling and Tolerance in Cystic Fibrosis Phe508del

Withdrawn
NCT02948322Not Applicable

Cardiac (CMRI) Assessment of Acromegaly

Completed
NCT02598791Not Applicable

GIP/GLP-1 Co-Activity in Subjects With Obesity: Lowering of Food Intake

Completed
NCT01966627

Genetics of Fatty Liver Disease in Children

Completed
NCT01960231

The Effect of ß-cell Specific Glucokinase Mutation on Glucose Homeostasis and Insulin Secretion in a MODY-2 Family

Unknown
NCT03190148Not Applicable

Glucose Metabolism in Pregnant Women With a History of Bariatric Surgery, as Well as Three to Six Months After Delivery.

Completed
NCT03165643

The DNA Methylation of ARHGEF11 in Macrosomia

Completed
NCT02669524Not Applicable

Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defect in Patients With Type 2 Diabetes

Completed
NCT02573662

Metabolic Complications Following Knee Injury in Young and Middle Aged Patients

Unknown
NCT01377961Not Applicable

Effect of Lycopene and Isoflavones on Glucose Metabolism

Withdrawn
NCT01347801Not Applicable

Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1

Completed
NCT02134860Not Applicable

Bed Rest, Alternate Daily Fasting and Incretin Effect

Completed
NCT01492283

Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without Diabetes

Completed
NCT02130505Not Applicable

Inflammatory Aspects of Glucose in Hyperlipidemia and Diabetes

Completed
NCT00926133

Type 2 Diabetes and Acute Myocardial Infarction

Unknown

All 19 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
19